Showing results (931-940 of 1,157) with videos related to

Sort By:
Pageof 116
British Journal of Pharmacology|August 4, 2018
Effects of non-euphoric plant cannabinoids on muscle quality and performance of dystrophic mdx miceFabio Arturo Iannotti, Ester Pagano, Aniello Schiano Moriello, et al.
The Journal of Nutrition|June 25, 2009
Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker ratsBarbara Batetta, Mikko Griinari, Gianfranca Carta, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 8, 2001
Exogenous anandamide protects rat brain against acute neuronal injury in vivoM van der Stelt, W B Veldhuis, G W van Haaften, et al.
Trends in Pharmacological Sciences|March 23, 2015
Endocannabinoid signaling at the periphery: 50 years after THCMauro Maccarrone, Itai Bab, Tamás Bíró, et al.
The Journal of Experimental Medicine|June 1, 1996
Autoreactive cytotoxic T lymphocytes in human immunodeficiency virus type 1-infected subjectsF di Marzo Veronese, D Arnott, V Barnaba, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 10, 2004
Development of the first ultra-potent "capsaicinoid" agonist at transient receptor potential vanilloid type 1 (TRPV1) channels and its therapeutic potentialGiovanni Appendino, Luciano De Petrocellis, Marcello Trevisani, et al.
Biochemical and Biophysical Research Communications|February 22, 2001
Highly selective CB(1) cannabinoid receptor ligands and novel CB(1)/VR(1) vanilloid receptor "hybrid" ligandsV Di Marzo, T Bisogno, L De Petrocellis, et al.
Journal of Medicinal Chemistry|May 14, 2009
Rational design, synthesis, and pharmacological properties of new 1,8-naphthyridin-2(1H)-on-3-carboxamide derivatives as highly selective cannabinoid-2 receptor agonistsClementina Manera, Giuseppe Saccomanni, Barbara Adinolfi, et al.
Acta Neuropathologica Communications|July 11, 2024
Early biomarkers in the presymptomatic phase of cognitive impairment: changes in the endocannabinoidome and serotonergic pathways in Alzheimer's-prone mice after mTBIFrancesca Guida, Monica Iannotta, Anna Lauritano, et al.
Neuropharmacology|July 12, 2008
The analgesic effect of N-arachidonoyl-serotonin, a FAAH inhibitor and TRPV1 receptor antagonist, associated with changes in rostral ventromedial medulla and locus coeruleus cell activity in ratsVito de Novellis, Enza Palazzo, Francesca Rossi, et al.
Pageof 116